LY-404187

From WikiMD's Medical Encyclopedia

Revision as of 01:26, 20 February 2025 by Prab (talk | contribs) (CSV import)

LY-404187 is a potent and selective AMPAR potentiator. It has been shown to have potential use in the treatment of schizophrenia and related conditions, and has been investigated for its nootropic effects.

Pharmacology

LY-404187 is a potent and selective AMPA receptor potentiator, which means it enhances the activity of the AMPA receptor. The AMPA receptor is one of the three main types of ionotropic glutamate receptors, and it plays a key role in the fast synaptic transmission of excitatory signals in the brain.

LY-404187 has been shown to have potential use in the treatment of schizophrenia and related conditions. Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. It is characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior.

In addition to its potential use in the treatment of schizophrenia, LY-404187 has also been investigated for its nootropic effects. Nootropics, also known as "smart drugs", are substances that can improve cognitive function, particularly executive functions, memory, creativity, or motivation, in healthy individuals.

Clinical Trials

LY-404187 has undergone clinical trials to evaluate its safety and efficacy in the treatment of schizophrenia. The results of these trials have shown that LY-404187 is safe and well-tolerated, and it has demonstrated potential efficacy in improving the cognitive deficits associated with schizophrenia.

See Also

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
  • LY-404187
    LY-404187
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=LY-404187&oldid=6334248"